Business Description
Protalix BioTherapeutics is a New Jersey-based company that develops and sells medical treatments derived from plant cells. Its current products address Gaucher disease and Fabry disease, while additional treatments for gout and certain immune-related conditions are progressing through clinical trials. The company works alongside several global partners, including Pfizer and Chiesi Farmaceutici, to advance and distribute its therapies.
